Blood Res.  2014 Mar;49(1):65-66. 10.5045/br.2014.49.1.65.

Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy

• Niscola P
• Tendas A
• Scaramucci L
• Giovannini M
• Piccioni D
• de Fabritiis P

• KMID: 2172826
• DOI: http://doi.org/10.5045/br.2014.49.1.65

Abstract

No abstract available.

MeSH Terms

Leukemia, Myeloid, Acute*
Leukemia, Myelomonocytic, Chronic*

Reference

1. Parikh SA, Tefferi A. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol. 2012; 87:610–619. PMID: 22615103.

2. Courville EL, Wu Y, Kourda J, et al. Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia. Mod Pathol. 2013; 26:751–761. PMID: 23307061.

3. Breccia M, Voso MT, Alimena G. Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far? Leuk Res. 2013; 37:204–205. PMID: 23174191.

4. Kim YJ, Jang JH, Kwak JY, Lee JH, Kim HJ. Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations. Blood Res. 2013; 48:87–98. PMID: 23826577.

5. Wijermans PW, Ruter B, Baer MR, Slack JL, Saba HI, Lubbert M. Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML). Leuk Res. 2008; 32:587–591. PMID: 17881052.

6. Onida F, Kantarjian HM, Smith TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood. 2002; 99:840–849. PMID: 11806985.

7. Thorpe M, Montalvao A, Pierdomenico F, Moita F, Almeida A. Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: a case series and literature review. Leuk Res. 2012; 36:1071–1073. PMID: 22607959.

8. Costa R, Abdulhaq H, Haq B, et al. Activity of azacitidine in chronic myelomonocytic leukemia. Cancer. 2011; 117:2690–2696. PMID: 21656746.

9. Fianchi L, Criscuolo M, Breccia M, et al. High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study. Leuk Lymphoma. 2013; 54:658–661. PMID: 22873829.